Niall Balfour, CEO, Tower Cold Chain, discusses the current challenges in the pharmaceutical cold chain and highlights how pharmaceutical manufacturers can ensure safe delivery of shipments, from mass-market to clinical trials.
Key insights:
- There is growing demand for tangible sustainability, traceability and digitalisation, and mounting regulation within cold chain solutions.
- Pharma manufacturers are compelled to seek out packaging solutions which fundamentally meet a core criterion: robust, reliable and reusable.
- Tower developed a solution to suit the growing demand for personalised medicines, small batch shipments and last-mile delivery.
It goes without saying that the pharmaceutical industry has some of the most stringent supply chain requirements of any market. Not only do many biopharmaceuticals require temperature-controlled preservation throughout their journey from manufacturer to patient, but there is growing demand for tangible sustainability, traceability and digitalisation, and mounting regulation to provide a clear, consistent framework for excellence.